Works

Skip to main content

Part of the Food and Drug Law Commons

2022

How Public Health Informed Lawmaking Would Address the Rising Synthetic Opioid Death Toll, Jennifer S. Bard
Brooklyn Law Review

2021

Copying Copyright: Adopting a Fair Use Defense in Patent Law in Times of Public Health Crisis, Kellie C. Van Beck
Brooklyn Law Review

High Time for a Change: How the Relationship Between Signatory Countries and the United Nations Conventions Governing Narcotic Drugs Must Adapt to Foster a Global Shift in Cannabis Law, Alexander Clementi
Brooklyn Journal of International Law

An Analysis of the Patent Linkage System and Development of the Biosimilar Industry in Taiwan, Jerry I-H Hsiao
Brooklyn Journal of International Law

Freedom Without Opportunity: Using Medicare Policy and CMS Mechanisms to Anticipate the Platform Economy’s Pitfalls and Ensure Healthcare Platform Workers Are Fairly Paid, Kim A. Aquino
Brooklyn Law Review

The Fight Over Frankenmeat: the FDA as the Proper Agency to Regulate Cell-Based “Clean Meat”, Zoe A. Bernstein
Brooklyn Law Review

2020

False Foods: Harmonizing the EU and US Organics Programs, Elizabeth G. Fudge
Brooklyn Journal of International Law

THE HEAVY HAND OF AMAZON: A SELLER NOT A NEUTRAL PLATFORM, Edward J. Janger, Aaron D. Twerski
Brooklyn Journal of Corporate, Financial & Commercial Law

(Almost) No Bad Drugs: Near-Total Products Liability Immunity for Pharmaceuticals Explained, Anita Bernstein
Faculty Scholarship

2019

PHARMACEUTICAL DRUG PRICING: THE INTERNET AS A SOLUTION FOR THIS HEALTH ISSUE TURNED FINANCIAL ISSUE, Thomas P. Kelly
Brooklyn Journal of Corporate, Financial & Commercial Law

Global Implementation of Soda Taxes: Is There a Better Solution for Combatting Obesity?, Lauren Cedeno
Brooklyn Journal of International Law

Something to Wine About: What Proposed Revisions to Wine Labeling Requirements Mean for Growers, Producers, and Consumers, Deborah Soh
Brooklyn Journal of Corporate, Financial & Commercial Law

Lactose’s Intolerance: The Role of Manufacturers’ Rights and Commercial Free Speech in Big Dairy’s Fight to Restrict Use of the Term “Milk”, Kathleen Justis
Brooklyn Law Review

Got Mylk?: The Disruptive Possibilities of Plant Milk, Iselin Gambert
Brooklyn Law Review

Direct-to-Consumer Calls to Action: Lowering the Volume of Claims and Disclosures in Prescription Drug Broadcast Advertisements, Andrew Andrzejewski
Brooklyn Law Review

2018

The Demise of Drug Design Litigation Death by Federal Preemption, Aaron Twerski
Faculty Scholarship

Swimming Upstream: The Need to Resolve Inconsistency in the FDA's Fishy Regulatory Scheme, Kelsie Kelly
Journal of Law and Policy

Passing the Baton: The Effect of the International Olympic Committee's Weak Anti-Doping Laws in Dealing with the 2016 Russian Olympic Team, Saroja Cuffey
Brooklyn Journal of International Law

The “Deeming Rule”: The FDA’s Destruction of the Vaping Industry, Lauren H. Greenberg
Brooklyn Law Review

2017

The Death of Private Practice: How the Rising Cost of Healthcare is Destroying Physician Autonomy, Oliver Owaid
Brooklyn Journal of Corporate, Financial & Commercial Law

Abuse of the Hatch-Waxman Act: Mylan's Ability to Monopolize Reflects Weaknesses, Kieran Meagher
Brooklyn Journal of Corporate, Financial & Commercial Law

2016

The New York Pharmaceutical Cost Transparency Act: How a Narrow View of the Prescription Drug Pricing Puzzle Renders a Well-intentioned Bill Irrational, John G. Curran
Brooklyn Law Review

Potholes: DUI Law in the Budding Marijuana Industry, Zack G. Goldberg
Brooklyn Law Review

Perpetual Twilight: How the USDA's Change to the Sunset Process Violates the Organic Foods Production Act of 1990, Valentina Lumaj
Brooklyn Law Review

The Uneasy Case for Food Safety Liability Insurance, John Aloysius Cogan Jr.
Brooklyn Law Review

Tainted: Food, Identity, and the Search for Dignitary Redress, Melissa Mortazavi
Brooklyn Law Review

2009

An Information Prescription for Prescription Drug Regulation, Anita Bernstein, Joseph Bernstein
Faculty Scholarship

2007

Enhancing Drug Effectiveness and Efficacy Through Personal Injury Litigation, Anita Bernstein
Faculty Scholarship

2005

Liability For Direct Advertising of Drugs to Consumers: An Idea Whose Time Has Not Come, Aaron Twerski
Faculty Scholarship

2001

Drug Designs are Different, Aaron Twerski, J. A. Henderson
Faculty Scholarship

2000

Measuring Culpability by Measuring Drugs? Three Reasons to Re-evaluate the Rockefeller Drug Laws, Susan Herman
Faculty Scholarship

1997

Formed by Thalidomide: Mass Torts as a False Cure for Toxic Exposure, Anita Bernstein
Faculty Scholarship

1986

With Liberty and Justice for All: An Essay on Agent Orange and Choice of Law, Aaron Twerski
Faculty Scholarship